Skip to main content

Table 3 Clinicopathological features of iCCA patients

From: The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Variables

No. of patients

50

 Male

20

 Female

30

Age (years)

 <60

15

 ≥60

35

Etiology

 HBV

13

 HCV

9

 Hepatolithiasis

8

 PSC

1

 NA

19

Liver cirrhosis

 Yes

20

 No

30

Tumor differentiation

 Well

20

 Moderately

19

 Poorly

11

Tumor size (cm)

 <5

40

 >5

10

Tumor number

 Single

37

 Multiple

13

Prognosis

 Better

 

 (≥ 3 years)

14

 Poorer

 (< 3 years)

36

Lymph node metastasis

 Yes

21

 No

29

Lung metastasis

 Yes

6

 No

44

  1. Abbreviations: NA not available, PSC primary sclerosing cholangitis